Ascendis Pharma (ASND)
(Delayed Data from NSDQ)
$133.46 USD
+0.33 (0.25%)
Updated May 10, 2024 04:00 PM ET
After-Market: $133.59 +0.13 (0.10%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 9/3/24 |
---|---|
Current Quarter | -1.35 |
EPS Last Quarter | -2.48 |
Last EPS Surprise | -57.96% |
ABR | 1.46 |
Earnings ESP
|
-4.11% |
---|---|
Current Year | -4.69 |
Next Year | -0.26 |
EPS (TTM) | -9.61 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 98.47M | 124.30M | 478.35M | 770.43M |
# of Estimates | 5 | 5 | 5 | 5 |
High Estimate | 107.96M | 154.05M | 529.22M | 908.28M |
Low Estimate | 87.90M | 108.80M | 436.64M | 679.26M |
Year ago Sales | 51.59M | 52.02M | 288.27M | 478.35M |
Year over Year Growth Est. | 90.87% | 138.94% | 65.94% | 61.06% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.35 | -1.01 | -4.69 | -0.26 |
# of Estimates | 6 | 5 | 8 | 7 |
Most Recent Consensus | -1.95 | -1.69 | -5.46 | 0.00 |
High Estimate | -0.98 | -0.50 | -2.75 | 2.08 |
Low Estimate | -1.95 | -1.69 | -6.53 | -2.08 |
Year ago EPS | -2.35 | -3.12 | -9.24 | -4.69 |
Year over Year Growth Est. | 42.55% | 67.63% | 49.24% | 94.40% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 1 | 1 | 1 | 1 |
Up Last 30 Days | 2 | 2 | 2 | 3 |
Up Last 60 Days | 1 | 2 | 2 | 3 |
Down Last 7 Days | 0 | 0 | 1 | 0 |
Down Last 30 Days | 2 | 2 | 5 | 2 |
Down Last 60 Days | 2 | 2 | 5 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.35 | -1.01 | -4.69 | -0.26 |
7 Days Ago | -1.41 | -1.07 | -4.66 | -0.46 |
30 Days Ago | -1.36 | -0.97 | -4.18 | -0.42 |
60 Days Ago | -1.33 | -0.97 | -4.16 | -0.42 |
90 Days Ago | -1.33 | -0.97 | -4.16 | -0.42 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.40 | -1.14 | -4.96 | -0.24 |
Zacks Consensus Estimate | -1.35 | -1.01 | -4.69 | -0.26 |
Earnings ESP | -4.11% | -12.62% | -5.91% | 6.15% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -2.48 | -1.66 | -3.12 | -2.35 | NA |
Estimate | -1.57 | -2.15 | -2.63 | -2.68 | NA |
Difference | -0.91 | 0.49 | -0.49 | 0.33 | -0.15 |
Surprise | -57.96% | 22.79% | -18.63% | 12.31% | -10.37% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more